No Data
Global Trade to Decline in 2025 Amid Increased Tariff Uncertainty, WTO Says
Coa Trading HD - The interim financial results are proceeding smoothly towards achieving the Financial Estimates for the fiscal year ending June 2025.
Koa Shoji Holdings <9273> is a holding company of a group engaged in the import and sale of pharmaceutical raw materials and the manufacture and sale of pharmaceuticals, listed on the Tokyo Stock Exchange Main Board. Starting with the import and sale of generic pharmaceutical raw materials (raw material segment), the company is now also focusing on the manufacture and sale of pharmaceuticals primarily composed of injectable drugs, as well as contract manufacturing of pharmaceuticals (pharmaceutical segment). Through the steady promotion of its medium to long-term business plan, the company aims for continued growth. The second quarter of the fiscal year ending June 2025.
List of convertible stocks (Part 5) [List of stocks with Parabolic Cigna Corp signals]
○ List of stocks changed to Sell in the market Code Stock Name Closing Price SAR Main Board <9009> Keisei 1425 1583 <9045> Keihan HD 32983475 <9048> Meitetsu 17781820 <9076> Seino HD 22292279 <9273> Koa Shoji HD 704747 <9319> Chuo Warehouse 14401528 <9435> Hikari Communications 3760039220 <947
List of stocks breaking through the clouds (weekly chart) (part 1)
○ List of stocks surpassing the cloud market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Main Board <1332> Nissui 857 848.5 842 <1333> Maruha Nichiro 319730842914.5 <1379> Hokuto 18491833.751824 <1720> Tokyu Construction 800744.25763 <1721> Comsys HD 32863071.753196
Koa Shoji Holdings Reports Strong Financial Growth in 2024
Koa Shoji HD --- In the second quarter, there was an increase in revenue and double-digit growth in profits, and an announcement of an increase in Dividends at the end of the period.
Koa Shōji Holdings <9273> announced its consolidated financial results for the second quarter of the fiscal year ending June 2025 on the 12th. Revenue increased by 7.7% year-on-year to 12.259 billion yen, operating profit rose by 28.0% to 3.063 billion yen, ordinary profit increased by 25.6% to 3.065 billion yen, and net profit attributable to the parent company's Shareholders grew by 31.1% to 2.049 billion yen. The revenue from the raw material sales business was 8.012 billion yen (a 1.7% increase compared to the same period last year), and the segment profit was 1.
